Tadalafil

CAS 171596-29-5 25 API suppliersSmall Molecule

Overview

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. It helps in relaxing muscles of the blood vessels, increasing blood flow to specific areas of the body.

API suppliers (25)

Suppliers of Tadalafil evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India14China4Netherlands1

Country recorded for 19 of 25 suppliers.

14 of 25 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (121 approved US products), the latest listed US patent on Tadalafil expires 24 Dec 2038. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

Erectile DysfunctionPulmonary HypertensionBenign Prostatic Hyperplasia
Verified Supplier Partner

Do you supply Tadalafil? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.